Maria R Farcet

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 7

Top Topics

Replacement Therapy

Cross Sectional

Respiratory Syndrome Coronavirus

Monoclonal Antibody

Top Venues

Communications medicine

The Journal of infectious diseases

This page only lists publications with an associated author ORCID identifier.

Publications

Min-Hsin Chen, Ludmila Perelygina, LiJuan Hao, R Suzanne Beard, Cornelia Lackner, Maria R Farcet, Michael Karbiener, Joseph Icenogle, Thomas R Kreil
Neutralization of Rubella Vaccine Virus and Immunodeficiency-Related Vaccine-Derived Rubella Viruses by Intravenous Immunoglobulins. The Journal of infectious diseases (2024)
Philippe Pérot, Nicolas Da Rocha, Maria R Farcet, Thomas R Kreil, Marc Eloit
Human Circovirus is not detected in plasma pools for fractionation. Transfusion (2023)
Maria R Farcet, Cornelia Lackner, Andreas Schirmer, Thomas R Kreil
Tetanus antibodies in normal human immunoglobulin preparations. Vox sanguinis (2023)
Michael Karbiener, Maria R Farcet, Reinhard Ilk, Jessica Schreiner, James Lenart, Nicholas Powers, Joseph M Stewart, Hema Tallman, Thomas R Kreil
Longitudinal analysis of SARS-CoV-2 antibodies in 8000 U.S. first-time convalescent plasma donations. Transfusion 61 (4) (2021)
Angelika Wagner, Angela Guzek, Johanna Ruff, Joanna Jasinska, Ute Scheikl, Ines Zwazl, Michael Kundi, Hannes Stockinger, Maria R Farcet, Thomas R Kreil, Eva Hoeltl, Ursula Wiedermann
Neutralising SARS-CoV-2 RBD-specific antibodies persist for at least six months independently of symptoms in adults. Communications medicine 1 (2021)
Anna-Maria Kapsch, Maria R Farcet, Andreas Wieser, Monazza Q Ahmad, Tomoyuki Miyabayashi, Sally A Baylis, Johannes Blümel, Thomas R Kreil
Antibody-enhanced hepatitis E virus nanofiltration during the manufacture of human immunoglobulin. Transfusion 60 (11) (2020)
Christof Jungbauer, Lukas Weseslindtner, Lisa Weidner, Simon Gänsdorfer, Maria R Farcet, Eva Gschaider-Reichhart, Thomas R Kreil
Characterization of 100 sequential SARS-CoV-2 convalescent plasma donations. Transfusion 61 (1) (2020)